Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot–peptide conjugates

Proteases are enzymes that catalyse the breaking of specific peptide bonds in proteins and polypeptides. They are heavily involved in many normal biological processes as well as in diseases, including cancer, stroke and infection. In fact, proteolytic activity is sometimes used as a marker for some cancer types. Here we present luminescent quantum dot (QD) bioconjugates designed to detect proteolytic activity by fluorescence resonance energy transfer. To achieve this, we developed a modular peptide structure which allowed us to attach dye-labelled substrates for the proteases caspase-1, thrombin, collagenase and chymotrypsin to the QD surface. The fluorescence resonance energy transfer efficiency within these nanoassemblies is easily controlled, and proteolytic assays were carried out under both excess enzyme and excess substrate conditions. These assays provide quantitative data including enzymatic velocity, Michaelis–Menten kinetic parameters, and mechanisms of enzymatic inhibition. We also screened a number of inhibitory compounds against the QD–thrombin conjugate. This technology is not limited to sensing proteases, but may be amenable to monitoring other enzymatic modifications.

[1]  Christopher Andersen,et al.  The Name Game , 1977 .

[2]  Igor L. Medintz,et al.  A fluorescence resonance energy transfer-derived structure of a quantum dot-protein bioconjugate nanoassembly. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Mahajan,et al.  Novel mutant green fluorescent protein protease substrates reveal the activation of specific caspases during apoptosis. , 1999, Chemistry & biology.

[4]  John F. Kennedy,et al.  Fundamentals of enzyme kinetics (revised edition) , 1997 .

[5]  R. A. Doney,et al.  4. Probability and Random Processes , 1993 .

[6]  X. Puente,et al.  Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.

[7]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[8]  Igor L. Medintz,et al.  Self-assembled nanoscale biosensors based on quantum dot FRET donors , 2003, Nature materials.

[9]  Igor L. Medintz,et al.  Quantum dot-based multiplexed fluorescence resonance energy transfer. , 2005 .

[10]  J. Powers,et al.  Clostridium histolyticum collagenase: development of new thio ester, fluorogenic, and depsipeptide substrates and new inhibitors. , 1985, Biochemistry.

[11]  H. Yeh,et al.  Single-quantum-dot-based DNA nanosensor , 2005, Nature materials.

[12]  Rolf Hilgenfeld,et al.  Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs , 2003, Science.

[13]  W. Lehmann,et al.  Protease‐catalyzed incorporation of 18O into peptide fragments and its application for protein sequencing by electrospray and matrix‐assisted laser desorption/ionization mass spectrometry , 1996, Electrophoresis.

[14]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[15]  Xiaogang Peng,et al.  Formation of high-quality CdTe, CdSe, and CdS nanocrystals using CdO as precursor. , 2001, Journal of the American Chemical Society.

[16]  Wadih Arap,et al.  Design and validation of a bifunctional ligand display system for receptor targeting. , 2004, Chemistry & biology.

[17]  J. Mankovich,et al.  Regulation of Protein Phosphatase 2A Activity by Caspase-3 during Apoptosis* , 1998, The Journal of Biological Chemistry.

[18]  P. Gaffney,et al.  The International and “NIH” Units for Thrombin - How Do They Compare? , 1995, Thrombosis and Haemostasis.

[19]  Igor L. Medintz,et al.  Fluorescence resonance energy transfer between quantum dot donors and dye-labeled protein acceptors. , 2003, Journal of the American Chemical Society.

[20]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[21]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[22]  Yufeng Wang,et al.  Data-mining approaches reveal hidden families of proteases in the genome of malaria parasite. , 2003, Genome research.

[23]  J. Matthew Mauro,et al.  Self-Assembly of CdSe−ZnS Quantum Dot Bioconjugates Using an Engineered Recombinant Protein , 2000 .

[24]  J. Weitz,et al.  New anticoagulant therapy. , 2005, Annual review of medicine.

[25]  D. E. Benson,et al.  General, high-affinity approach for the synthesis of fluorophore appended protein nanoparticle assemblies. , 2005, Chemical communications.

[26]  M. Levy,et al.  Quantum‐Dot Aptamer Beacons for the Detection of Proteins , 2005, Chembiochem : a European journal of chemical biology.

[27]  A. Miyawaki Visualization of the spatial and temporal dynamics of intracellular signaling. , 2003, Developmental cell.

[28]  L. Makings,et al.  A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases. , 2002, Assay and drug development technologies.

[29]  Hans Matter,et al.  Recent advances in the design of matrix metalloprotease inhibitors. , 2004, Current opinion in drug discovery & development.

[30]  Itamar Willner,et al.  Lighting-up the dynamics of telomerization and DNA replication by CdSe-ZnS quantum dots. , 2003, Journal of the American Chemical Society.

[31]  J. Lakowicz Principles of fluorescence spectroscopy , 1983 .

[32]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[33]  Igor L. Medintz,et al.  Surface-immobilized self-assembled protein-based quantum dot nanoassemblies. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[34]  J. Saulnier,et al.  Assays of matrix metalloproteinases (MMPs) activities: a review. , 2005, Biochimie.

[35]  G. Grimmett,et al.  Probability and random processes , 2002 .

[36]  Igor L. Medintz,et al.  Quantum-dot-based multiplexed fluorescence resonance energy transfer , 2005, SPIE BiOS.

[37]  K. O. Elliston,et al.  A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.

[38]  W. Wiczk,et al.  Fluorogenic peptide substrates containing benzoxazol-5-yl-alanine derivatives for kinetic assay of cysteine proteases. , 2005, Analytical biochemistry.

[39]  Igor L. Medintz,et al.  A hybrid quantum dot-antibody fragment fluorescence resonance energy transfer-based TNT sensor. , 2005, Journal of the American Chemical Society.

[40]  Atsushi Miyawaki,et al.  Lighting up cells: labelling proteins with fluorophores. , 2003, Nature cell biology.

[41]  A. Szabó,et al.  Effects of polyethylene glycol on stability of α-chymotrypsin in aqueous ethanol solvent , 2004 .

[42]  I. Richard The genetic and molecular bases of monogenic disorders affecting proteolytic systems , 2005, Journal of Medical Genetics.

[43]  N. Thornberry,et al.  A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.

[44]  Deepak L. Bhatt,et al.  Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors. , 2005, American heart journal.

[45]  R. Ala-aho,et al.  Collagenases in cancer. , 2005, Biochimie.

[46]  Shimon Weiss,et al.  Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. , 2004, Journal of the American Chemical Society.

[47]  R. Tsien,et al.  Creating new fluorescent probes for cell biology , 2002, Nature Reviews Molecular Cell Biology.

[48]  J. Dixon,et al.  A Yersinia Effector and a Pseudomonas Avirulence Protein Define a Family of Cysteine Proteases Functioning in Bacterial Pathogenesis , 2002, Cell.

[49]  M. Bawendi,et al.  (CdSe)ZnS Core-Shell Quantum Dots - Synthesis and Characterization of a Size Series of Highly Luminescent Nanocrystallites , 1997 .

[50]  J. Hainfeld,et al.  Ni-NTA-gold clusters target His-tagged proteins. , 1999, Journal of structural biology.

[51]  S. Steinberg The Cardiovascular Actions of Protease-Activated Receptors , 2005, Molecular Pharmacology.

[52]  R. Ala-aho,et al.  Matrix metalloproteinases as therapeutic targets in cancer. , 2005, Current cancer drug targets.

[53]  D. Giegel,et al.  ICE processing and kinetic mechanism , 1997, Journal of cellular biochemistry.